The CEOs of Atlanta-based GeoVax Labs and Chembio Diagnostics, Inc. came together to promote new rapid HIV testing and vaccine developments last week ahead of World AIDS Day on Dec. 1.

Bob McNally, Ph.D., CEO of GeoVax Labs, highlights his company’s efforts in a search for an HIV/AIDS vaccine, while Larry Siebert, CEO of Chembio Diagnostics, Inc., discusses advancements in rapid testing for the disease in a short video promo.

Both men say the most important issue in the fight against HIV is awareness. According to McNally, an estimated 2.7 million people per year contract the disease.